214 related articles for article (PubMed ID: 21259444)
1. 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.
Zahov S; Drews A; Hess M; Schulze Elfringhoff A; Lehr M
ChemMedChem; 2011 Mar; 6(3):544-9. PubMed ID: 21259444
[TBL] [Abstract][Full Text] [Related]
2. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
3. 1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: Effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability.
Sundermann T; Fabian J; Hanekamp W; Lehr M
Bioorg Med Chem; 2015 May; 23(10):2579-92. PubMed ID: 25862211
[TBL] [Abstract][Full Text] [Related]
4. 1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A
Althaus J; Hake T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016; 31(sup1):131-140. PubMed ID: 27162011
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A
Arnsmann M; Hanekamp W; Elfringhoff AS; Lehr M
Eur J Med Chem; 2017 Jan; 125():1107-1114. PubMed ID: 27810597
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies on 1-heteroaryl-3-phenoxypropan-2-ones acting as inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: replacement of the activated ketone group by other serine traps.
Sundermann T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):653-63. PubMed ID: 26153239
[TBL] [Abstract][Full Text] [Related]
7. 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
Fritsche A; Elfringhoff AS; Fabian J; Lehr M
Bioorg Med Chem; 2008 Apr; 16(7):3489-500. PubMed ID: 18321717
[TBL] [Abstract][Full Text] [Related]
8. 1-(5-Carboxyindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis and properties of bioisosteric benzimidazole, benzotriazole and indazole analogues.
Bovens S; Kaptur M; Elfringhoff AS; Lehr M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2107-11. PubMed ID: 19327988
[TBL] [Abstract][Full Text] [Related]
9. 1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.
Bovens S; Schulze Elfringhoff A; Kaptur M; Reinhardt D; Schäfers M; Lehr M
J Med Chem; 2010 Dec; 53(23):8298-308. PubMed ID: 21067218
[TBL] [Abstract][Full Text] [Related]
10. Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure.
Fabian J; Hanekamp W; Thomas MH; Olivier JL; Lehr M
Chem Biol Interact; 2013 Nov; 206(2):356-63. PubMed ID: 24120545
[TBL] [Abstract][Full Text] [Related]
11. 1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: bioisosteric replacement of the carboxylic acid and carboxamide moiety.
Hess M; Schulze Elfringhoff A; Lehr M
Bioorg Med Chem; 2007 Apr; 15(8):2883-91. PubMed ID: 17320401
[TBL] [Abstract][Full Text] [Related]
12. Structure based design of novel irreversible FAAH inhibitors.
Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
[TBL] [Abstract][Full Text] [Related]
13. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of benzalkonium chloride-induced skin inflammation in mice by an indol-1-ylpropan-2-one inhibitor of cytosolic phospholipase A2 α.
Roebrock K; Wolf M; Bovens S; Lehr M; Sunderkötter C
Br J Dermatol; 2012 Feb; 166(2):306-16. PubMed ID: 21929537
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of 3-dodecanoylindole-2-carboxylic acid inhibitors of cytosolic phospholipase A2alpha-mediated arachidonic acid release in intact platelets: variation of the keto moiety.
Ghasemi A; Elfringhoff AS; Lehr M
J Enzyme Inhib Med Chem; 2005 Oct; 20(5):429-37. PubMed ID: 16335050
[TBL] [Abstract][Full Text] [Related]
17. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Holtfrerich A; Hanekamp W; Lehr M
Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
[TBL] [Abstract][Full Text] [Related]
18. 1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity.
Drews A; Bovens S; Roebrock K; Sunderkötter C; Reinhardt D; Schäfers M; van der Velde A; Schulze Elfringhoff A; Fabian J; Lehr M
J Med Chem; 2010 Jul; 53(14):5165-78. PubMed ID: 20583844
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.
Tomoo T; Nakatsuka T; Katayama T; Hayashi Y; Fujieda Y; Terakawa M; Nagahira K
J Med Chem; 2014 Sep; 57(17):7244-62. PubMed ID: 25102418
[TBL] [Abstract][Full Text] [Related]
20. Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2alpha: optimization of in vitro potency and rat pharmacokinetics for oral efficacy.
Lee KL; Behnke ML; Foley MA; Chen L; Wang W; Vargas R; Nunez J; Tam S; Mollova N; Xu X; Shen MW; Ramarao MK; Goodwin DG; Nickerson-Nutter CL; Abraham WM; Williams C; Clark JD; McKew JC
Bioorg Med Chem; 2008 Feb; 16(3):1345-58. PubMed ID: 17998165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
